Rachel K. King, co-founder and CEO of GlycoMimetics, Inc. (GMI), joins Rich Bendis to discuss being the CEO of a publicly traded clinical-stage biotechnology company, gene therapy, and the BioHealth Capital Region.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.